A Smarter Approach to IVF Preimplantation Genetic Testing (PGT) is a method used during In Vitro Fertilization (IVF) to check embryos for genetic abnormalities before implantation. This process helps select genetically healthy embryos, reducing the chances of miscarriage and inherited conditions while improving the likelihood of a successful pregnancy.
At NCare IVF Kannur, we provide precise genetic screening to support couples who may have a family history of genetic conditions, recurrent miscarriages, or unsuccessful IVF attempts. By identifying potential concerns early, PGT helps ensure a smoother fertility journey with better outcomes.
Considering PGT for your IVF treatment? Schedule a consultation with our experts to understand how genetic testing can support your fertility journey.
Preimplantation Genetic Testing (PGT) is a multi-step process conducted during an IVF cycle to ensure only healthy embryos are selected for implantation. Each stage is carefully performed to maximize success rates while maintaining embryo integrity.
Eggs are retrieved from the ovaries and fertilized with sperm in a controlled laboratory environment. The resulting embryos are monitored for 5-6 days until they reach the blastocyst stage, the ideal phase for genetic testing.
A microscopic biopsy is performed on each embryo, where a small number of cells are carefully removed. This step is conducted using precise techniques to ensure the embryo remains unaffected and continues developing normally.
The extracted cells undergo genetic analysis, where specialists examine them for chromosomal abnormalities, single-gene disorders, structural rearrangements, polygenic risk factors (PGT-P), or via non-invasive screening (niPGT).
Once the analysis is complete, only chromosomally normal and genetically healthy embryos are selected for transfer.
A carefully selected healthy embryo is transferred into the uterus, increasing the likelihood of implantation and a successful pregnancy. A pregnancy test is conducted 12-14 days after embryo transfer to confirm the outcome.
Preimplantation Genetic Testing (PGT) includes various screening methods, each designed to address specific genetic concerns. Selecting the right test based on individual medical history and fertility goals improves the chances of a successful pregnancy.
PGT-A helps detect missing or extra chromosomes in embryos. Chromosomal imbalances may lead to conditions such as Down syndrome, Turner syndrome, and Edwards syndrome, which can affect pregnancy success.
PGT-M identifies embryos affected by inherited genetic conditions caused by mutations in a single gene. This test helps couples with a known history of genetic disorders reduce the risk of passing these conditions to their child.
PGT-SR is designed for individuals with chromosomal structural variations, such as translocations, inversions, or deletions. These genetic changes can lead to implantation failure, pregnancy loss, or birth defects.
PGT-P is a cutting-edge test that screens embryos for polygenic conditions β conditions influenced by multiple genes and lifestyle factors. These include common diseases like heart disease, type 2 diabetes, and certain cancers.
niPGT is a non-invasive testing method that analyzes cell-free DNA released by embryos into the culture medium. It offers genetic screening without embryo biopsy.
Preimplantation Genetic Testing (PGT) helps identify genetic abnormalities before embryo implantation, ensuring a healthier pregnancy. While not required for every IVF cycle, it is highly recommended for individuals or couples with specific medical histories.
Our fertility specialists provide expert genetic counseling, helping couples understand the benefits of PGT and whether it is the right choice for their journey to parenthood.
Copyright Β© NCare IVF